Trial Profile
Controllability and Real Life Efficacy of Bonviva 3 mg iv Quarterly vs. Oral Alendronate Generics.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary) ; Alendronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms VIVA
- Sponsors Roche
- 06 Jul 2012 Actual patient number 6054 added as reported by ClinicalTrials.gov.
- 06 Jul 2012 Actual end date Mar 2012 added as reported by ClinicalTrials.gov.
- 06 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.